Fanny Baran-Marszak

10PUBLICATIONS
65CO-AUTHORS
Haematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersCancer cell biologyMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Sep 19, 2025
Clinical and transcriptomic characterization of patients with chronic lymphocytic leukemia harboring t(14;19): an ERIC study.

Andrea Visentin, Enrico Gaffo, Moritz Fürstenau

|Apr 24, 2025
ATM aberrations in chronic lymphocytic leukemia: del(11q) rather than ATM mutations is an adverse-prognostic biomarker.

Birna Thorvaldsdottir, Larry Mansouri, Lesley-Ann Sutton

|Apr 14, 2025
The Broad Spectrum of TP53 Mutations in CLL: Evidence of Multiclonality and Novel Mutation Hotspots.

Grégory Lazarian, Bernard Leroy, Floriane Theves

|Mar 06, 2025
TP53 Mutations Detected by NGS Are a Major Clinical Risk Factor for Stratifying Mantle Cell Lymphoma.

Grégory Lazarian, Lotfi Chemali, Merieme Bensalah

|Dec 23, 2023
Identification of the Axis β-Catenin-BTK in the Dynamic Adhesion of Chronic Lymphocytic Leukemia Cells to Their Microenvironment.

Imane Mihoub, Tareck Rharass, Souhaïl Ouriemmi

|Jun 20, 2023
Inhibition of a new AXL isoform, AXL3, induces apoptosis of mantle cell lymphoma cells.

Pascal Gelebart, May Eriksen Gjerstad, Susanne Benjaminsen

Pageof 2

Frequent Collaborators

4 joint publications

Kostas Stamatopoulos

4 joint publications

Paolo Ghia

4 joint publications

Zadie Davis

4 joint publications

Panagiotis Baliakas